Log In
Print
BCIQ
Print
Print this Print this
 

Gemzar, gemcitabine

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionNucleoside analog
Molecular Target Ribonucleotide reductase ; DNA polymerase
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today